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Abstract
In response to infection or effective vaccination, naive antigen-specific CD8+ T cells undergo a
dramatic highly orchestrated activation process. Initial encounter with an appropriately activated
antigen-presenting cell leads to blastogenesis and an exponential increase in antigen-specific
CD8+ T cell numbers. Simultaneously, a dynamic differentiation process occurs, resulting in
formation of both primary effector and long-lived memory cells. Current findings have emphasized
the heterogeneity of effector and memory cell populations with the description of multiple cellular
subsets based on phenotype, function, and anatomic location. Yet, only recently have we begun to
dissect the underlying factors mediating the temporal control of the development of distinct effector
and memory CD8+ T cell sublineages. In this review we will focus on the requirements for mounting
an effective CD8+ T cell response and highlight the elements regulating the differentiation of effector
and memory subsets.
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Introduction
The practical concept of immunologic memory has existed for many centuries, from
Thucydides’ (ca. 430 BC) observation that surviving plague victims did not secondarily
contract the disease to the use of variolation to prevent smallpox by the ancient Chinese (ca.
1000 AD) and Edward Jenner’s observation that milk maids exposed to cowpox rarely acquired
smallpox (1796 AD). Jenner’s vaccination scheme led to a scientific explosion in trying to
understand the mechanisms behind acquired protection. To date, vaccines have eliminated or
minimized many devastating diseases throughout the world. Most of the effective vaccines in
use today rely on the generation of neutralizing antibody responses.1 However, for some
pathogens, such as malaria and HIV, vaccines aimed at inducing neutralizing antibody
responses have been largely unsuccessful.2,3 In addition, although the influenza virus vaccine
provides a level of protection to some individuals, it is less than ideal because antigenic drift
forces yearly vaccination with predicted emerging serotypes.4 For these infections and others,
vaccines geared toward generation of CD8+ T-cell immunity may provide protection.5–8 This
is true for two reasons: CD8+ T cells generally react to epitopes derived from proteins with
less strain to strain variation9 and the life cycle of certain microbes does not lend itself to
inhibition by antibody neutralization, while CD8+ T cells provide sterilizing immunity.10 Thus,
CD8+ T cells play a crucial role in the control of infection by intracellular pathogens, such as
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certain viruses, bacteria, and protozoan parasites. Additionally, CD8+ T cells are able to limit
tumor development and growth.11
Only in the past few decades have the cellular and molecular mechanisms behind memory T-
cell development begun to be elucidated. Much of that work has been greatly aided by
technological advances, such as flow cytometry, knockout and transgenic mice, gene arrays,
and peptide: major histocompatibility complex p (MHC) tetrameric reagents as well as the
more recent application of laser-based confocal and two-photon microscopy. These techniques
have enabled us to quantify, characterize, localize, and isolate antigen-specific T cells
throughout the entire immune response. Additionally, broad cell genetic analysis through the
use of DNA microarrays and deep sequencing has given us large data sets that are indicative
of either effective or ineffective CD8+ T-cell-mediated immune responses12,13 (K.M. Khanna
et al., University of Connecticut Health Center, unpublished observation). As such, our
understanding of the events leading to the successful generation of T-cell memory has been
significantly enhanced in recent years, but much remains unresolved.
Phases of the T cell response
Mature mammals maintain a pool of naive antigen-specific T cells that is capable of responding
to a vast array of peptide antigens. Recent studies have elucidated that in laboratory mice there
are approximately between 15 and 1000 antigen-specific CD8+ T cells14–16 and 10 and 200
CD4+ T cells17 specific for any given MHC/peptide epitope combination. Although analysis
of many more specificities is needed before generalizations can be made, naive T-cell
frequencies in this range would enable the host to respond to approximately 106–107 different
peptides. However, the total number of antigens to which mice can respond is likely larger as
a result of cross-reactive T-cell receptors (TCRs).18,19 Activation of naive T cells is highly
dependent on dendritic cells (DCs),20 but other antigen-presenting cells (APCs), such as
macrophages, may also be used under certain conditions.21 The initiation of the T-cell response
to a pathogen occurs in an exquisitely orchestrated process whereby the antigen is enriched in
the T-cell zones of the lymphoid organs via capture and concentration by APCs. This process
increases the odds of the rare antigen-specific T cell encountering its cognate antigen presented
on MHC molecules expressed by DCs. Initial studies suggested that only a short encounter
with antigen was necessary for optimal CD8 T-cell expansion and subsequent memory
formation.22,23 However, more recent studies indicate that prolonged interactions with antigen-
bearing APCs are necessary for the optimal generation of effector and memory T cells.24–28
The activation of CD8+ T cells is dependent on at least three signals: 1) antigenic stimulation
through the TCR; 2) costimulation through molecules such as CD28, CD40, 4-1BB, CD27,
ICOS, and/or OX40; and 3) stimulation through receptors for inflammatory cytokines,
especially IL-12 and interferon (IFN)-α.29–31 Naive antigen-specific CD8+ T cells receiving
all three of these signals will undergo robust expansion, generating a large effector CD8+ T-
cell population. In addition to the exponential increase in cell numbers, activation results in
the acquisition by the responding cells of several effector functions, such as the expression of
cytokines (i.e., IFN-γ and tumor necrosis factor [TNF]-α) and perforin and granzyme
molecules, which are necessary for cytolytic activity, and in some cases via nonlytic
mechanisms for antiviral defense.32 Furthermore, at this point the armed effector T cells,
whether CD8+ or CD4+ T cells, will migrate to virtually all the tissues of the body33,34 on a
mission to patrol the body with the goal of removing all infected cells.
After this rapid expansion, the effector cell population undergoes a catastrophic contraction
phase whereby approximately 95% of effector cells die by apoptosis, which is mediated largely
by the ratio of the expression of survival versus apoptotic factors, such as Bcl-2, Bclx, and Bim
and Fas pathways.35–41 Ultimately, the remaining pathogen-specific T cells form the memory
T-cell population. These memory CD8+ T cells will then persist long term in the host in an
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antigen-independent42 and TCR-independent43 but cytokine-dependent manner.44,45 The
cytokines responsible for the long-term maintenance of the memory CD8+ T-cell population
are members of the γc-cytokine family, with IL-7 or perhaps thymic stromal lymphopoietin
(TSLP) enhancing memory cell survival,46–48 while IL-15 is essential for the slow homeostatic
turnover of the memory cells.44,45 Several salient features of memory cells enable them to
rapidly respond when they are called back to duty. First, memory T cells may persist in
relatively large numbers, compared to naive T-cell frequencies, in multiple tissues of the body,
33,34 which positions them on the front line near potential points of pathogen entry into
nonlymphoid tissues, such as the lung, intestines, and skin. Second, memory T cells are able
to rapidly re-express effector molecules, such as cytokines and proteins of the lytic machinery,
even prior to cell division in some cases.49,50 The ability to rapidly respond is a result of, at
least in part, the hyper-responsive state of memory T cells compared to naive T cells.51–54
Thus, the proper training of naive CD8+ T-cell recruits results in the formation of an operational
army of effector and memory CD8+ T cells that can protect the host from the present infection
and be poised to win future battles with the same pathogen.
Definition of memory T cell subsets
Earlier studies demonstrated the existence of at least two memory T-cell subpopulations based
on the expression of different homing molecules, specifically CD62L (L-selectin) and the
receptor for the CCL19 and CCL21 chemokines CCR7.33,34,55,56 CD62L and CCR7 along
with the β2 integrin, αxβ2, are required for entry of naive57 and presumably memory T cells to
enter lymph nodes (LNs). However, memory T cells may enter a reactive LN in a CD62L- and
CCR7-independent manner.58 CCR7 is also important for positioning of lymphocytes and
APCs within the spleen59 and appears to be required for exit of cells from nonlymphoid tissues
by controlling entry into afferent lymphatics.60,61 Memory T cells expressing both these
receptors are termed central memory cells (TCM), while those lacking expression of both
molecules are termed effector memory cells (TEM). Differential expression of both CD62L and
CCR7 results in memory cell subpopulation localization to different anatomical sites with the
TCM largely confined to the LNs, spleen, and blood, while TEM are localized in peripheral
nonlymphoid tissues (e.g., lung, liver, intestine), spleen, and blood.33,34 TEM may also be
present in LNs perhaps as a result of migration via afferent lymphatics from non-lymphoid
tissues. Additionally, central and effector memory T cells exhibit distinct functional abilities,
34,56,62 which intriguingly could play a role in the different protective abilities of each subset
against future antigen encounters.63,64 Furthermore, tissue-resident CD8+ TEM are important
in the maintenance of latent α-herpesvirus infection and undergo rapid expansion following
viral reactivation.32,65–67
The origin of TEM versus TCM has been a matter of considerable study and debate. Early work
demonstrates that, with increasing time after immunization, the proportion of CD62Lhigh cells
increases within the memory population.68 Initially this phenomenon was thought to be a result
of re-expression of CD62L by CD62Llow TEM converting to CD62Lhigh TCM, but this appears
to be the result of artificially high naive CD8+ T-cell-precursor frequencies.14,69–71 More
likely, on the basis of the available evidence, the increasing predominance of CD62Lhigh
TCM in the memory population is a result of the increased turnover rate of those cells relative
to the CD62Llow TEM, which divide at a slower rate.14,70 However, the strict classification of
memory cells based on expression of CD62L and CCR7 alone is unlikely to be all inclusive
as further phenotypic heterogeneity within the memory T-cell pool has been observed.72,73
Thus, classifications of memory T cells should also account for specific characteristics of the
immune response related to the inciting infectious agent or immunization scheme. For example,
following respiratory influenza virus infection subsets of cells in the lung and lung-draining
mediastinal LNs express a unique pattern of activation markers as a result of the presence of
low levels of persistent antigen.73–76 Furthermore, following γ-herpesvirus infections in both
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mice and humans, CD8+ T cells responding to either lytic-cycle or latent-cycle proteins have
distinct activation profiles resembling TEM and TCM, respectively.77–79 Additionally, the level
of antigenic persistence and localization of such persistence has a dramatic impact on the
phenotype, functionality, and survival/maintenance of the antigen-specific CD8+ T cell
responding to persistent infections.80–85 Thus, classifications of memory cell subsets should
be made with the appropriate contextual considerations.
Models describing the origins of memory CD8+ T cells
When, where, and how memory T cells and their associated subsets are formed is an area of
intense study. One important fact to consider when generating any model to explain effector
and memory CD8+ T-cell differentiation is that a single naive antigen-specific CD8+ T cell of
fixed avidity has the potential to form every effector and memory subset observed during the
CD8+ T-cell response.86 This finding suggests that after activation the progeny of the initial
cell must integrate distinct downstream signals, resulting in generation of heterogeneous
populations of effector and memory cells. Although past debate has focused on whether
memory T cells can develop without transiting an effector stage,87 recent results88,89 show
that effector cells are the source of memory T cells. These studies used reporter mice in which
CD8+ or CD4+ T cells exhibiting granzyme B or IFN-γ promoter activity were irreversibly
labeled by means of Cre-mediated recombination to identify effector T cells and their offspring.
88,89 The results support a linear differentiation model in which naive T cells are activated,
expand, and differentiate into effector T cells, after which a small proportion of the effector
cells survives to form the long-lived memory population (Fig. 1). Nevertheless, the
heterogeneity found in both the effector and memory cell pools must also be accounted for in
any differentiation scheme.56,90,91
Here we propose an early fate determination model to explain the current data related to effector
and memory cell differentiation (Fig. 1). After initial activation the early effector CD8+ T-cell
population appears to be phenotypically homogeneous, being CD127low KLRG1low
CD27high. In keeping with the genetic labeling experiments,88,89 this population of early
effector CD8+ T cells will have gained full effector cell functions, expressing the effector
molecules granzyme B and IFN-γ, and as a result all the subsequent effector and memory
populations will be similarly genetically labeled. As the immune response continues,
substantial heterogeneity within the effector cell population can be observed by the peak of the
CD8+ T-cell response. The majority of the effector CD8+ T cells present at this time are
terminally differentiated effector cells, which are relatively short lived, while a much smaller
population of memory precursor effector cells also exist.90–93 Additionally, we have recently
observed further heterogeneity within the memory precursor effector cell population, with both
CD62Lhigh TCM and CD62Llow TEM precursors being present by 5 days after infection (J.J.
Obar et al., manuscript submitted), which fits with our previous data indicating that the TCM
and TEM represent fixed cell lineages, at least based on CD62L expression.14,70 However, it
remains unknown whether a memory precursor cell upon further stimulation can give rise to
short-lived effector cells or if a CD62Lhigh TCM memory precursor can become a CD62Llow
TEM memory precursor.
Another controversial topic of research is the question of when and how the heterogeneity
within the effector population is induced. The early fate determination model proposed here
suggests that the early effector CD8+ T-cell population is homogeneous, but this seems unlikely
given that within the next 24–48 h diversity becomes evident in the population. Thus,
heterogeneity at the level of the earliest signaling events apparently controls long-term
outcomes. Taken to the extreme, the model of Reiner and colleagues suggests that asymmetric
division occurring during the first cell division results in proximal and distal daughter cells
that have different lineage potential, producing effector and memory lineages, respectively.
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94 However, this model has not explained how such lineages may be maintained during the
ensuing robust cellular division and ongoing acquisition of antigen- and cytokine-driven
signals. In this scheme, genetic “imprinting” would occur during the initial T-cell–APC
encounter. Thus, it remains possible that heterogeneity exists at a genetic level within the early
effector CD8+ T-cell population and that deterministic events continue to occur downstream
of initial activation. At this point, an early fate determination model, as described, best fits the
available data and largely explains the cellular heterogeneity observed during both the effector
and memory stages.
Requirements for generating effector cell heterogeneity
As proposed in the early fate determination model, the effector cell population contains both
terminally differentiated effector cells and memory precursors at the peak of the CD8+ T-cell
response. Originally, the memory precursor population of effector CD8+ T cells was identified
based solely on their retained expression of IL-7Rα.46,90 More recently, such memory
precursor cells were shown to lack expression of killer cell lectin-like receptor G1 (KLRG1),
while the terminally differentiated effector cells express high levels of KLRG1.91–93
Additionally, CD27 expression remains high on the memory precursor population and
decreases on the short-lived effector cell population95 (J.J. Obar & L. Lefrançois, unpublished
observation). Recently the factors regulating the differentiation of these two effector cell
subpopulations have begun to be elucidated. As previously mentioned, activation of a naive
antigen-specific CD8+ T cell is highly dependent on three separate signals: antigenic
stimulation through the TCR, costimulation, and stimulation via inflammatory cytokines. Each
of these three signals alone or in combination has the potential to direct the responding
CD8+ T cells to differentiation toward one cell fate or another: terminal effector cell or memory
precursor.
Central to the activation cascade is the interaction of the TCR with cognate antigen presented
by the appropriate MHC molecule. It has been demonstrated that the overall strength of TCR
stimulation, an accumulation of the magnitude and duration of TCR: pMHC (peptide MHC)
interaction, can direct the magnitude of the T-cell response,96–99 but this does not seem to
drastically alter the differentiation pattern of the responding CD8+ T cells91 (J.J. Obar et al.,
manuscript submitted). After TCR engagement, CD8+ T cells upregulate numerous
costimulatory molecules. It is well established that such receptors play an important role in the
clonal expansion and survival of the responding antigen-specific CD8+ T-cell population,100,
101 but much less is known about their impact on effector cell differentiation leading to memory
subset development. Although more work is needed, CD27 or 4–1BB costimulation does not
appear to dramatically alter the development of short-lived effector CD8+ T cells (J.J. Obar &
L. Lefrançois, unpublished observation). One recent study indicates that following Listeria
monocytogenes infection OX40 plays a significant role in the differentiation of the memory
precursor pool, as OX40−/− CD8+ T cells generated reduced numbers of CD127high
KLRG1low cells, which led to poor memory development.102 Given the large number of
potential costimulators, the role of each costimulator in influencing effector and memory cell
heterogeneity requires substantial further exploration.
The effects of cytokines on expansion and differentiation of effector and memory CD8+ T cells
has also been a topic of considerable scrutiny. It is well documented that both type I and type
II IFNs as well as IL-12 can act directly on responding CD8+ T cells to enhance their survival
and/or expansion.31,103–108 Furthermore, some of these inflammatory cytokines have also
been shown to have a dramatic effect on the differentiation of responding antigen-specific
CD8+ T cells. For example, low levels of inflammation, such as are present during DC
vaccination, shift the balance toward enhanced generation of memory precursors,91,109,110
while high levels of inflammation, such as during infections, lead to the rapid and preferential
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expansion of terminally differentiated KLRG1high effector cells.91,111,112 Specifically, IL-12
has been shown to influence the differentiation of terminally differentiated short-lived effector
cells,91 and this inflammatory event must be directly coupled temporally with antigenic
stimulation of the T cell.112 Additionally, IL-2 immune complexes given as a vaccine adjuvant
will enforce differentiation of the KLRG1high short-lived effector cell population.93 One
inflammatory pathway of note, which does not act directly on the responding antigen-specific
CD8+ T cells, is the MyD88 pathway, which is crucial in mediating signals through Toll-like
receptors and IL-1 cytokine family members.113 However, this pathway is likely important in
CD8+ T-cell differentiation but may act upstream of the CD8+ T cell by directing the activation
of the APC through modulation of the costimulatory and inflammatory environment. Thus, we
have begun to understand the integration of the signaling pathways mediated by the three
classes of activation signals leading to generation of short-lived apparently terminally
differentiated effector cells. However, one glaring observation is the absence of the
identification of the factors that are important in directing the differentiation of the memory
precursor effector cell population and derivative memory subsets.
Recently, an elegant study by Palmer and colleagues demonstrated that the CART domain
within the transmembrane region of the TCRβ chain is required for the formation of CD8+ T-
cell memory.114 Further, this effect is likely mediated through formation of the immunological
synapse and subsequent signaling through protein kinase C (PKC)-θ and nuclear factor (NF)-
κB. However, this study did not determine whether memory precursors were ever formed or
whether all antigen-specific CD8+ T cells failed to survive the contraction phase. Therefore,
this work demonstrates that the type or “strength” of initial signaling received by the responding
naive antigen-specific CD8+ T cell may have a drastic effect on the future outcome of the
response, but further work is needed to definitively separate memory cell differentiation from
cell survival.
One important insight into memory cell differentiation has come from the profiling of
transcription factor expression in the different T-cell populations. The transcription factors that
have been explored during CD8+ T-cell responses include T-bet, Eomes, Blimp1, Bcl6, and
Id2. To date, the most extensively studied transcription factors during an antigen-specific
CD8+ T-cell response have been the pair of T-box transcription factors, T-bet and Eomes.
Reiner and colleagues have shown that T-bet and Eomes are critical in the regulation of effector
and memory cell differentiation, respectively.115 Overexpression of T-bet in effector cells leads
to the enhanced generation of short-lived terminal effector cells.91 Furthermore, the
transcription factor Blimp1 has been shown to be highly expressed in those cells that also
express T-bet.116 This suggests that T-bet and Blimp1 together may direct a transcriptional
program that leads to the formation and expansion of the terminally differentiated short-lived
effector cell population. Blimp1 activity can be opposed by the transcription factor Bcl6, which
is important in directing the differentiation of germinal center B cells into either memory cells
or plasma cells.117 Intriguingly, Bcl6 appears to also play a role in the differentiation of memory
CD8+ T cells as Bcl6−/− mice have reduced numbers of antigen-specific memory CD8+ T cells,
while the opposite is true of Bcl6 transgenic mice.118,119 Thus, by understanding the factors
that regulate these pivotal transcription factors, we will garner a better understanding of the
complex regulation inherent to the differentiation of distinct effector and memory CD8+ T-cell
subsets.
Regulation of L-selectin expression
L-selectin (CD62L) plays a key role, together with CCR7, in enabling naive T cells to enter
lymph nodes from the blood through the high endothelial venules.120,121 As such, CD62L and
CCR7 expression are tightly regulated to enable the redistribution of effector T cells that
downregulate these homing receptors following activation.122–126 Much of what is known
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about the control of CD62L expression has been determined using in vitro activation systems.
In these studies, the regulation of CD62L after TCR engagement occurs in a three-step process.
127,128 Initially, within 6–8 h of activation, CD62L is shed from the cell surface by proteolytic
cleavage through the action of the protease TACE/Adam17.126 Next, between 24–48 h, CD62L
is re-expressed on the cell surface of the activated T cells. Finally, relatively late after initial
activation, sell gene activity can be modified by mechanisms that are only now being defined.
Recently, the minimal promoter region of the sell gene was identified and five transcription
factors were found to play a role in mediating transcription driven by the sell promoter. These
transcription factors are Ets1, Irf1, Klf2, Mzf1, and Sp1.129 Importantly, Klf2 is known to play
a key role in regulating CD62L expression in naive T cells and thymocytes.130 Interestingly,
recent work has begun to elucidate the factors that not only regulate promoter activity of the
sell gene but also regulate activation of the protease TACE/Adam17, which is responsible for
CD62L cleavage (Fig. 2). Elegant in vitro studies from Cantrell and colleagues show that the
p110δ subunit of phosphatidylinositol-3-kinase (PI[3]K) is critical in not only the modulation
of TACE/Adam17 activity but also the genetic regulation of sell promoter activity.131 Signaling
through the TCR results in activation of the p110δ subunit of PI(3)K, resulting in subsequent
activation of the Erk1/2 pathway. Active Erk1/2 can then phosphorylate TACE/Adam17,
promoting translocation to the cell membrane where it can cleave the CD62L protein from the
cell surface, resulting in the transient early loss of CD62L. Sustained or permanent genetic
regulation of CD62L expression occurs at later time points after activation and appears to be
mediated, at least in part, by members of the γc-cytokine family.131 Signaling through the IL-2R
complex results in strong activation of the PI(3)K pathway, while signals mediated by the
IL-15R complex result in apparently weaker activation of the PI(3)K pathway.132 Furthermore,
in vitro studies show that antigen-mediated activation of CD8+ T cells in the presence of IL-2
or IL-15 results in the generation of TEM- or TCM-like effector cells, respectively.131,133,134
Activation of the PI(3)K path-way by γc-cytokines appears to regulate sell gene expression
through regulation of mammalian target of rapamycin (mTOR) activity, which subsequently
modulates the activity of the transcription factor Klf2. As such, the strong signal through PI
(3)K initiated by IL-2 activates mTOR, resulting in inhibition of Klf2. In contrast, IL-15 signals
will only weakly activate the PI(3)K pathway, resulting in inefficient mTOR activation, leaving
Klf2 free to enhance sell gene expression as well as the genes encoding other receptors
important to lymphocyte migration, including S1P1 and CCR7.130 More recent work has also
found that the transcription factor Foxo1 can regulate CD62L expression on naive T cells
perhaps via IL-7R signaling,135,136 but whether Foxo1 directly binds to the sell promoter or
works indirectly through Klf2 is unknown. To date, the work using conditional knockout mice,
in which the importance of Klf2 and Foxo1 in the regulation of sell gene expression was
demonstrated, has been exclusively performed using naive T cells.130,135,136 However, gene-
profiling studies have shown that early after activation Klf2 mRNA and protein levels decrease,
while at later time points during the effector phase and in memory cells Klf2 levels increase.
137–139 Therefore, it will be interesting to explore whether CD62L expression is regulated in
a similar manner within the central memory CD8+ T cells and how the two transcription factors
Klf2 and Foxo1 are regulated within the memory precursor subpopulations described earlier.
It should also be kept in mind that epigenetic modification of the sell locus could also play an
important role in regulation of CD62L expression, although that aspect has yet to be analyzed.
In any case, a more thorough understanding of the factors regulating the Foxo1 and Klf2
transcription factors will provide insight into the process of central memory CD8+ T-cell
development.
Molecular determinants of central and effector memory differentiation
Initially, in vitro studies indicated that the strength and/or duration of TCR engagement could
play an important role in directing the differentiation of CD4+ and CD8+ T cells into either
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central or effector memory-like cells.140,141 Naive CD4+ T cells stimulated in vitro by a weak
stimulus underwent proliferation but preferentially trafficked to the lymph nodes, indicative
of TCM.142 Similarly, priming of CD8+ T cells in vitro at a low DC: T-cell ratio preferentially
generates TCM, while higher ratios tend to generate TEM.143,144 In vivo studies using graded
numbers of transgenic CD8+ T cells indicate that when high numbers of antigen-specific
CD8+ T cells are transferred prior to activation, the CD62Lhigh central memory population
emerges more rapidly.69–71 This finding also holds true when examining the endogenous,
polyclonal, antigen-specific CD8+ T-cell populations of different naive T-cell frequencies.14
These data suggest that competition for antigen by the responding CD8+ T cells may direct the
differentiation of central and effector memory lineages. Further support for this hypothesis
comes from studies in which mice treated with Flt3L to increase the number of DCs are given
high numbers of TCR transgenic CD8+ T cells.70 Following immunization, the resultant
memory population contains fewer CD62Lhigh memory cells compared to controls, again
supporting the concept that the antigen-bearing APC: T-cell ratio regulates CD62L expression.
However, the results of these studies could be affected by the possibility that transfer of high
numbers of antigen-specific CD8+ T cells may result in more rapid clearance of the pathogen,
resulting in an altered inflammatory milieu.145 To circumvent this problem, we have
established a system to modulate antigen availability by administration of a monoclonal
antibody (25-D1.16) specific for the SIINFEKL peptide (derived from chicken ovalbumin)
presented in the context of the class I MHC molecule H-2Kb.146 Using this protocol during
vesicular stomatitis virus encoding ovalbumin (VSV-ova) infection resulted in an increase in
CD62Lhigh central memory precursor cells early during the response (J.J. Obar et al.,
manuscript submitted). Furthermore, this was likely not because of an alteration of the
inflammatory environment as the effect was observed only for CD8+ T cells specific for
SIINFEKL/Kb; CD8+ T cells specific for the irrelevant epitope VSV-N/Kb were left unaffected.
Thus, limiting antigen availability enhanced central memory T-cell development. Additionally,
the temporal window for altering the phenotype of the resultant memory CD8+ T-cell
population was brief. Antigen availability was necessary for up to 4 days for optimal expansion
of the antigen-specific CD8+ T-cell population. However, competition for antigen only
appeared to affect the Tem-Tcm lineage decision during the period up to approximately 72 h
after infection (J.J. Obar et al., manuscript submitted). Thus, the present data strongly support
the concept that the level of stimulation via the TCR regulates the differentiation of central and
effector memory T-cell subsets.
It is also known that CD4+ T-cell help is important in mounting effective CD8+ T-cell responses
in some cases.147–154 The provision of help to CD8+ T cells by CD4+ T cells is thought to act
through the activation of the DCs, resulting in upregulation of costimulatory molecules and
cytokine production,155,156 in addition to the direct production of inflammatory cytokines and
chemokines by the CD4+ T cells.157,158 So-called “helpless” memory CD8+ T cells, those
raised in the absence of CD4+ T cells, have an apparent defect in their long-term survival and
recall capacity,149,151,159 suggesting that conditioning of memory precursors by CD4+ T cells
in the primary response plays an important role in generating functional CD8+ memory T cells.
The mechanism by which this occurs has yet to be defined, and our published and preliminary
results do not support this model152 (J.J. Obar & L. Lefrançois, unpublished observation).
Nonetheless, the memory CD8+ T-cell population produced in CD4+ T-cell-deficient animals
contains an increased proportion of CD62Lhigh TCM.149 These results suggest that CD4+ T-
cell help may impact the lineage decision directing central versus effector memory CD8+ T-
cell development, although at what stage of the response this occurs is unknown. The two most
likely downstream intermediates modulated by CD4+ T cells are the expression of
costimulatory molecules on the APCs and the expression of inflammatory cytokines by the
APCs and/or CD4+ T cells themselves. Once again, as with the generation of effector cell
subpopulations, very little is known regarding the role of costimulatory molecules in the
generation of memory cell heterogeneity. Of note is that the use of immature DCs or
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intercellular adhesion molecule 1 (ICAM1)−/− DCs for immunization results in the generation
of a memory population that is skewed toward the central memory phenotype.160 Thus, not
only do the large numbers of potential costimulators need to be studied but the extensive family
of adhesion molecules that can alter the duration of T-cell–APC interactions also require
additional exploration with respect to their potential roles in memory development.
On the other hand, the role of cytokines, specifically members of the γc-cytokine family, has
been investigated in memory cell subset differentiation. In vitro studies have demonstrated that
activation of CD8+ T cells through the TCR in the presence of IL-2 leads to accumulation of
cells with a CD62Llow effector memory phenotype, while activation in the presence of IL-15
leads to the accumulation of CD62Lhigh central memory phenotype cells.131,133,134
Furthermore, our in vivo data using CD25−/− (IL-2Rα) mixed bone marrow chimeras or
IL-15−/− mice support these observations, with more CD62Lhigh cells present in the memory
precursor CD8+ T cells from the CD25-deficient population and less being found in the absence
of IL-15 (J.J. Obar et al., manuscript submitted), which fits with previous findings showing
that memory CD8+ T cells are skewed toward a TCM phenotype in CD25-deficient cells.161,
162 The γc-cytokine family contains six members (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21), all of
which could impact the memory subset differentiation decision. Of note, in vitro studies using
IL-21 as a growth factor have shown that cell-surface CD62L expression is maintained on the
activated CD8+ T cells.163 Thus, a more thorough examination of the γc-cytokine family as
well as other inflammatory cytokines, such as IFN-α/β, IFN-γ, and the IL-12 family, may shed
light on the factors directing differentiation of the different memory subsets.
Future perspectives
Much has been learned about the origins of effector and memory CD8+ T cells over the past
few years. However, many of the molecular mechanisms behind these processes remain ill
defined. More specifically, we have readily been able to identify some of the factors important
in the generation of terminally differentiated short-lived effector cells, but the factors regulating
memory precursor effector cell differentiation have largely eluded us. An understanding of
such factors will be critically important in the rational design of vaccination protocols that may
induce larger numbers of long-lived and protective memory T cells. Furthermore, much of our
knowledge base with respect to memory CD8+ T cells comes from primary infection, but most
human vaccines require multiple administrations of attenuated pathogens or co-administration
of protein antigens with adjuvants, such as alum. Thus, we must begin to examine the
differentiation of memory cells after multiple antigenic encounters and what effect the adjuvant
used has on the subsequent memory cell development.164 Furthermore, what relationship the
peripheral memory cells in restricted environments, such as the skin, gut, and brain, has with
the systemic population remains to be explored as these cells do not seem to be efficiently
repopulated by the systemic pool.165 We are beginning to make progress toward the generation
of rational vaccines, as evidenced by the development of the human papillomavirus vaccine,
which uses virus-like particles,166 but much remains to be discovered and successfully applied
to clinical settings.
Acknowledgments
The authors thank all the members of the Lefrançois lab for insightful discussions shaping this paper. This work was
funded by the U.S. National Institutes of Health grants (Leo Lefrancois) and F32AI074277 (Joshua J. Obar).
References
1. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008;47:401–409.
[PubMed: 18558875]
Obar and Lefrançois Page 9
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
2. Nabel GJ. Mapping the future of HIV vaccines. Nat Rev Microbiol 2007;5:482–484. [PubMed:
17571457]
3. Todryk SM, Hill AV. Malaria vaccines: the stage we are at. Nat Rev Microbiol 2007;5:487–489.
[PubMed: 17571459]
4. Hikono H, et al. T-cell memory and recall responses to respiratory virus infections. Immunol Rev
2006;211:119–132. [PubMed: 16824122]
5. Hill AV. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol 2006;6:21–
32. [PubMed: 16493425]
6. McMichael AJ. HIV vaccines. Annu Rev Immunol 2006;24:227–255. [PubMed: 16551249]
7. Brown LE, Kelso A. Prospects for an influenza vaccine that induces cross-protective cytotoxic T
lymphocytes. Immunol Cell Biol 2009;87:300–308. [PubMed: 19308073]
8. Masopust D. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity,
quality and location. J Intern Med 2009;265:125–137. [PubMed: 19093965]
9. Grebe KM, Yewdell JW, Bennink JR. Heterosubtypic immunity to influenza A virus: where do we
stand? Microbes Infect 2008;10:1024–1029. [PubMed: 18662798]
10. Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol 2003;21:29–
70. [PubMed: 12414723]
11. De Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer
development. Nat Rev Cancer 2006;6:24–37. [PubMed: 16397525]
12. Gaucher D, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune
responses. J Exp Med 2008;205:3119–3131. [PubMed: 19047440]
13. Querec TD, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in
humans. Nat Immunol 2009;10:116–125. [PubMed: 19029902]
14. Obar JJ, Khanna KM, Lefrancois L. Endogenous naive CD8+ T cell precursor frequency regulates
primary and memory responses to infection. Immunity 2008;28:859–869. [PubMed: 18499487]
15. Kotturi MF, et al. Naive precursor frequencies and MHC binding rather than the degree of epitope
diversity shape CD8+ T cell immunodominance. J Immunol 2008;181:2124–2133. [PubMed:
18641351]
16. Haluszczak C, et al. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes
memory phenotype cells bearing markers of homeostatic expansion. J Exp Med 2009;206:435–448.
[PubMed: 19188498]
17. Moon JJ, et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire
diversity and response magnitude. Immunity 2007;27:203–213. [PubMed: 17707129]
18. Nahill SR, Welsh RM. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the
virus-induced polyclonal cytotoxic T lymphocyte response. J Exp Med 1993;177:317–327. [PubMed:
8093891]
19. Selin LK, Nahill SR, Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition
of heterologous viruses. J Exp Med 1994;179:1933–1943. [PubMed: 8195718]
20. Jung S, et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by
exogenous cell-associated antigens. Immunity 2002;17:211–220. [PubMed: 12196292]
21. Pozzi LA, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8
T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol
2005;175:2071–2081. [PubMed: 16081773]
22. Kaech SM, Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a
developmental program in naive cells. Nat Immunol 2001;2:415–422. [PubMed: 11323695]
23. Van Stipdonk MJ, Lemmens EE, Schoenberger SP. Naive CTLs require a single brief period of
antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2001;2:423–429.
[PubMed: 11323696]
24. Obst R, Van Santen HM, Mathis D, Benoist C. Antigen persistence is required throughout the
expansion phase of a CD4(+) T cell response. J Exp Med 2005;201:1555–1565. [PubMed: 15897273]
25. Celli S, Lemaitre F, Bousso P. Real-time manipulation of T cell-dendritic cell interactions in vivo
reveals the importance of prolonged contacts for CD4+ T cell activation. Immunity 2007;27:625–
634. [PubMed: 17950004]
Obar and Lefrançois Page 10
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
26. Khanna KM, McNamara JT, Lefrancois L. In situ imaging of the endogenous CD8 T cell response
to infection. Science 2007;318:116–120. [PubMed: 17916739]
27. Sarkar S, et al. Strength of stimulus and clonal competition impact the rate of memory CD8 T cell
differentiation. J Immunol 2007;179:6704–6714. [PubMed: 17982060]
28. Blair DA, Lefrancois L. Increased competition for antigen during priming negatively impacts the
generation of memory CD4 T cells. Proc Natl Acad Sci USA 2007;104:15045–15050. [PubMed:
17827281]
29. Mescher MF, et al. Signals required for programming effector and memory development by CD8+
T cells. Immunol Rev 2006;211:81–92. [PubMed: 16824119]
30. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K. Innate inflammatory signals induced by
various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion
and memory formation. J Immunol 2006;177:1746–1754. [PubMed: 16849484]
31. Xiao Z, et al. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J
Immunol 2009;182:2786–2794. [PubMed: 19234173]
32. Knickelbein JE, et al. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1
reactivation from neuronal latency. Science 2008;322:268–271. [PubMed: 18845757]
33. Reinhardt RL, et al. Visualizing the generation of memory CD4 T cells in the whole body. Nature
2001;410:101–105. [PubMed: 11242050]
34. Masopust D, Vezys V, Marzo AL, Lefrançois L. Preferential localization of effector memory cells
in nonlymphoid tissue. Science 2001;291:2413–2417. [PubMed: 11264538]
35. Hildeman DA, et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member
bim. Immunity 2002;16:759–767. [PubMed: 12121658]
36. Wojciechowski S, et al. Bim mediates apoptosis of CD127(lo) effector T cells and limits T cell
memory. Eur J Immunol 2006;36:1694–1706. [PubMed: 16761315]
37. Wojciechowski S, et al. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell
homeostasis. J Exp Med 2007;204:1665–1675. [PubMed: 17591857]
38. Weant AE, et al. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity
and CD8+ T cell contraction. Immunity 2008;28:218–230. [PubMed: 18275832]
39. Hughes PD, et al. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune
responses and prevention of autoimmunity. Immunity 2008;28:197–205. [PubMed: 18275830]
40. Hutcheson J, et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early
onset of systemic autoimmunity. Immunity 2008;28:206–217. [PubMed: 18275831]
41. Green DR. Fas Bim boom! Immunity 2008;28:141–143. [PubMed: 18275825]
42. Murali-Krishna K, et al. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science
1999;286:1377–1381. [PubMed: 10558996]
43. Leignadier J, et al. Memory T-lymphocyte survival does not require T-cell receptor expression. Proc
Natl Acad Sci USA 2008;105:20440–20445. [PubMed: 19074272]
44. Schluns KS, et al. Cutting Edge: Requirement for IL-15 in the generation of primary and memory
antigen-specific CD8 T cells. J Immunol 2002;168:4827–4831. [PubMed: 11994430]
45. Becker TC, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8
T cells. J Exp Med 2002;195:1541–1548. [PubMed: 12070282]
46. Schluns KS, Kieper WC, Jameson SC, Lefrançois L. Interleukin-7 mediates the homeostasis of naive
and memory CD8 T cells in vivo. Nat Immunol 2000;1:426–432. [PubMed: 11062503]
47. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev
Immunol 2003;3:269–279. [PubMed: 12669018]
48. Klonowski KD, Williams KJ, Marzo AL, Lefrancois L. Cutting edge: IL-7-independent regulation
of IL-7 receptor alpha expression and memory CD8 T cell development. J Immunol 2006;177:4247–
4251. [PubMed: 16982855]
49. Tanchot C, et al. Modifications of CD8+ T cell function during in vivo memory or tolerance induction.
Immunity 1998;8:581–590. [PubMed: 9620679]
50. Whitmire JK, Eam B, Whitton JL. Tentative T cells: memory cells are quick to respond, but slow to
divide. PLoS Pathog 2008;4:e1000041. [PubMed: 18404208]
Obar and Lefrançois Page 11
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
51. Veiga-Fernandes H, et al. Response of naive and memory CD8+ T cells to antigen stimulation in vivo.
Nat Immunol 2000;1:47–53. [PubMed: 10881174]
52. Hussain SF, Anderson CF, Farber DL. Differential SLP-76 expression and TCR-mediated signaling
in effector and memory CD4 T cells. J Immunol 2002;168:1557–1565. [PubMed: 11823482]
53. Veiga-Fernandes H, Rocha B. High expression of active CDK6 in the cytoplasm of CD8 memory
cells favors rapid division. Nat Immunol 2004;5:31–37. [PubMed: 14647273]
54. Chandok MR, Farber DL. Signaling control of memory T cell generation and function. Semin
Immunol 2004;16:285–293. [PubMed: 15528073]
55. Hamann D, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells.
J Exp Med 1997;186:1407–1418. [PubMed: 9348298]
56. Sallusto F, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector
functions. Nature 1999;401:708–712. [PubMed: 10537110]
57. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep
paradigm. Cell 1994;76:301–314. [PubMed: 7507411]
58. Guarda G, et al. L-selectin-negative CCR7-effector and memory CD8+ T cells enter reactive lymph
nodes and kill dendritic cells. Nat Immunol 2007;8:743–752. [PubMed: 17529983]
59. Forster R, et al. CCR7 coordinates the primary immune response by establishing functional
microenvironments in secondary lymphoid organs. Cell 1999;99:23–33. [PubMed: 10520991]
60. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral
tissues and entry into afferent lymphatics. Nat Immunol 2005;6:895–901. [PubMed: 16116469]
61. Debes GF, et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues.
Nat Immunol 2005;6:889–894. [PubMed: 16116468]
62. Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human
naive, central memory, and effector memory CD4(+) T cells. J Exp Med 2001;194:1711–1719.
[PubMed: 11748273]
63. Lefrancois L. Development, trafficking, and function of memory T-cell subsets. Immunol Rev
2006;211:93–103. [PubMed: 16824120]
64. Lefrancois L, Marzo AL. The descent of memory T-cell subsets. Nat Rev Immunol 2006;6:618–623.
[PubMed: 16868553]
65. Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL. Herpes simplex virus-specific memory
CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity
2003;18:593–603. [PubMed: 12753737]
66. Wakim LM, et al. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science
2008;319:198–202. [PubMed: 18187654]
67. Gebhardt T, et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during
infection with herpes simplex virus. Nat Immunol 2009;10:524–530. [PubMed: 19305395]
68. Tripp RA, Hou S, Doherty PC. Temporal loss of the activated L-selectin-low phenotype for virus-
specific CD8+ memory T cells. J Immunol 1995;154:5870–5875. [PubMed: 7538535]
69. Wherry EJ, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat
Immunol 2003;4:225–234. [PubMed: 12563257]
70. Marzo AL, et al. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat
Immunol 2005;6:793–799. [PubMed: 16025119]
71. Badovinac VP, Haring JS, Harty JT. Initial T cell receptor transgenic cell precursor frequency dictates
critical aspects of the CD8(+) T cell response to infection. Immunity 2007;26:827–841. [PubMed:
17555991]
72. Unsoeld H, Pircher H. Complex memory T-cell phenotypes revealed by coexpression of CD62L and
CCR7. J Virol 2005;79:4510–4513. [PubMed: 15767451]
73. Hikono H, et al. Activation phenotype, rather than central- or effector-memory phenotype, predicts
the recall efficacy of memory CD8+ T cells. J Exp Med 2007;204:1625–1636. [PubMed: 17606632]
74. Zammit DJ, et al. Residual antigen presentation after influenza virus infection affects CD8 T cell
activation and migration. Immunity 2006;24:439–449. [PubMed: 16618602]
Obar and Lefrançois Page 12
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
75. Khanna KM, et al. In situ imaging reveals different responses by naive and memory CD8 T cells to
late antigen presentation by lymph node DC after influenza virus infection. Eur J Immunol
2008;38:3304–3315. [PubMed: 19009527]
76. Woodland DL, Kohlmeier JE. Migration, maintenance and recall of memory T cells in peripheral
tissues. Nat Rev Immunol 2009;9:153–161. [PubMed: 19240755]
77. Hislop AD, et al. EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell
phenotype, and immediate effector function. J Immunol 2001;167:2019–2029. [PubMed: 11489984]
78. Catalina MD, Sullivan JL, Brody RM, Luzuriaga K. Phenotypic and functional heterogeneity of EBV
epitope-specific CD8+ T cells. J Immunol 2002;168:4184–4191. [PubMed: 11937579]
79. Obar JJ, Crist SG, Gondek DC, Usherwood EJ. Different functional capacities of latent and lytic
antigen-specific CD8 T cells in murine gammaherpesvirus infection. J Immunol 2004;172:1213–
1219. [PubMed: 14707099]
80. Wherry EJ, et al. Viral persistence alters CD8 T cell immunodominance and tissue distribution and
results in distinct stages of functional impairment. J Virol 2003;77:4911–4927. [PubMed: 12663797]
81. Obar JJ, Crist SG, Leung EK, Usherwood EJ. IL-15-independent proliferative renewal of memory
CD8+ T cells in latent gammaherpesvirus infection. J Immunol 2004;173:2705–2714. [PubMed:
15294989]
82. Wherry EJ, et al. Antigen-independent memory CD8 T cells do not develop during chronic viral
infection. Proc Natl Acad Sci USA 2004;101:16004–16009. [PubMed: 15505208]
83. Obar JJ, et al. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and
enhances antiviral protection. J Virol 2006;80:8303–8315. [PubMed: 16912282]
84. Sheridan BS, Khanna KM, Frank GM, Hendricks RL. Latent virus influences the generation and
maintenance of CD8+ T cell memory. J Immunol 2006;177:8356–8364. [PubMed: 17142732]
85. Munks MW, et al. Four distinct patterns of memory CD8 T cell responses to chronic murine
cytomegalovirus infection. J Immunol 2006;177:450–458. [PubMed: 16785542]
86. Stemberger C, et al. A single naive CD8+ T cell precursor can develop into diverse effector and
memory subsets. Immunity 2007;27:985–997. [PubMed: 18082432]
87. Seder RA, Ahmed R. Similarities and differences in CD4(+) and CD8(+) effector and memory T cell
generation. Nat Immunol 2003;4:835–842. [PubMed: 12942084]
88. Harrington LE, et al. Memory CD4 T cells emerge from effector T-cell progenitors. Nature
2008;452:356–360. [PubMed: 18322463]
89. Bannard O, Kraman M, Fearon DT. Secondary replicative function of CD8+ T cells that had developed
an effector phenotype. Science 2009;323:505–509. [PubMed: 19164749]
90. Kaech SM, et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that
give rise to long-lived memory cells. Nat Immunol 2003;4:1191–1198. [PubMed: 14625547]
91. Joshi NS, et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates
via the graded expression of T-bet transcription factor. Immunity 2007;27:281–295. [PubMed:
17723218]
92. Sarkar S, et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory
fates. J Exp Med 2008;205:625–640. [PubMed: 18316415]
93. Rubinstein MP, et al. IL-7 and IL-15 differentially regulate CD8+ T cell subsets during contraction
of the immune response. Blood 2008;112:3704–3712. [PubMed: 18689546]
94. Chang JT, et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses.
Science 2007;315:1687–1691. [PubMed: 17332376]
95. Stonier SW, Ma LJ, Castillo EF, Schluns KS. Dendritic cells drive memory CD8 T cell homeostasis
via IL-15 transpresentation. Blood 2008;112:4546–4554. [PubMed: 18812469]
96. Wherry EJ, Puorro KA, Porgador A, Eisenlohr LC. The induction of virus-specific CTL as a function
of increasing epitope expression: responses rise steadily until excessively high levels of epitope are
attained. J Immunol 1999;163:3735–3745. [PubMed: 10490969]
97. Wherry EJ, Mcelhaugh MJ, Eisenlohr LC. Generation of CD8(+) T cell memory in response to low,
high, and excessive levels of epitope. J Immunol 2002;168:4455–4461. [PubMed: 11970989]
Obar and Lefrançois Page 13
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
98. Bullock TN, Mullins DW, Engelhard VH. Antigen density presented by dendritic cells in vivo
differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J Immunol
2003;170:1822–1829. [PubMed: 12574347]
99. Prlic M, Hernandez-Hoyos G, Bevan MJ. Duration of the initial TCR stimulus controls the magnitude
but not functionality of the CD8+ T cell response. J Exp Med 2006;203:2135–2143. [PubMed:
16908626]
100. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515–
548. [PubMed: 15771580]
101. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol
2005;23:23–68. [PubMed: 15771565]
102. Mousavi SF, et al. OX40 costimulatory signals potentiate the memory commitment of effector CD8
+ T cells. J Immunol 2008;181:5990–6001. [PubMed: 18941188]
103. Cousens LP, et al. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways
in promoting T cell interferon gamma responses during viral infection. J Exp Med 1999;189:1315–
1328. [PubMed: 10209048]
104. Badovinac VP, Tvinnereim AR, Harty JT. Regulation of antigen-specific CD8(+) T cell homeostasis
by perforin and interferon-gamma. Science 2000;290:1354–1358. [PubMed: 11082062]
105. Curtsinger JM, Johnson CM, Mescher MF. CD8 T cell clonal expansion and development of effector
function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol
2003;171:5165–5171. [PubMed: 14607916]
106. Haring JS, Corbin GA, Harty JT. Dynamic regulation of IFN-gamma signaling in antigen-specific
CD8+ T cells responding to infection. J Immunol 2005;174:6791–6802. [PubMed: 15905520]
107. Kolumam GA, et al. Type I interferons act directly on CD8 T cells to allow clonal expansion and
memory formation in response to viral infection. J Exp Med 2005;202:637–650. [PubMed:
16129706]
108. Whitmire JK, Tan JT, Whitton JL. Interferon-gamma acts directly on CD8+ T cells to increase their
abundance during virus infection. J Exp Med 2005;201:1053–1059. [PubMed: 15809350]
109. Badovinac VP, Porter BB, Harty JT. CD8+ T cell contraction is controlled by early inflammation.
Nat Immunol 2004;5:809–817. [PubMed: 15247915]
110. Badovinac VP, et al. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-
cell vaccination. Nat Med 2005;11:748–756. [PubMed: 15951824]
111. Wilson DC, Matthews S, Yap GS. IL-12 signaling drives CD8+ T cell IFN-gamma production and
differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection. J Immunol
2008;180:5935–5945. [PubMed: 18424713]
112. Cui W, Joshi NS, Jiang A, Kaech SM. Effects of Signal 3 during CD8 T cell priming: Bystander
production of IL-12 enhances effector T cell expansion but promotes terminal differentiation.
Vaccine 2009;27:2177–2187. [PubMed: 19201385]
113. Rahman AH, et al. MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion
during acute lymphocytic choriomeningitis virus infection. J Immunol 2008;181:3804–3810.
[PubMed: 18768833]
114. Teixeiro E, et al. Different T cell receptor signals determine CD8+ memory versus effector
development. Science 2009;323:502–505. [PubMed: 19164748]
115. Intlekofer AM, et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.
Nat Immunol 2005;6:1236–1244. [PubMed: 16273099]
116. Intlekofer AM, et al. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8
+ T cells. J Exp Med 2007;204:2015–2021. [PubMed: 17698591]
117. Benson MJ, Erickson LD, Gleeson MW, Noelle RJ. Affinity of antigen encounter and other early
B-cell signals determine B-cell fate. Curr Opin Immunol 2007;19:275–280. [PubMed: 17433651]
118. Ichii H, et al. Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nat
Immunol 2002;3:558–563. [PubMed: 12021781]
119. Ichii H, Sakamoto A, Kuroda Y, Tokuhisa T. Bcl6 acts as an amplifier for the generation and
proliferative capacity of central memory CD8+ T cells. J Immunol 2004;173:883–891. [PubMed:
15240675]
Obar and Lefrançois Page 14
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
120. Campbell JJ, et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high
endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol 1998;141:1053–1059.
[PubMed: 9585422]
121. Forster R, et al. CCR7 coordinates the primary immune response by establishing functional
microenvironments in secondary lymphoid organs. Cell 1999;99:23–33. [PubMed: 10520991]
122. Dailey MO, Gallatin WM, Weissman IL. The in vivo behavior of T cell clones: altered migration
due to loss of the lymphocyte surface homing receptor. J Mol Cell Immunol 1985;2:27–36.
[PubMed: 2978224]
123. Jung TM, Gallatin WM, Weissman IL, Dailey MO. Down-regulation of homing receptors after T
cell activation. J Immunol 1988;141:4110–4117. [PubMed: 3058798]
124. Jung TM, Dailey MO. Reversibility of loss of homing receptor expression following activation. Adv
Exp Med Biol 1988;237:519–524. [PubMed: 3075863]
125. Mobley JL, Dailey MO. Regulation of adhesion molecule expression by CD8 T cells in vivo. I.
Differential regulation of gp90MEL-14 (LECAM-1), Pgp-1, LFA-1, and VLA-4 alpha during the
differentiation of cytotoxic T lymphocytes induced by allografts. J Immunol 1992;148:2348–2356.
[PubMed: 1373165]
126. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte
adhesion cascade updated. Nat Rev Immunol 2007;7:678–689. [PubMed: 17717539]
127. Jung TM, Dailey MO. Rapid modulation of homing receptors (gp90MEL-14) induced by activators
of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface.
J Immunol 1990;144:3130–3136. [PubMed: 2182714]
128. Chao CC, Jensen R, Dailey MO. Mechanisms of L-selectin regulation by activated T cells. J Immunol
1997;159:1686–1694. [PubMed: 9257829]
129. Dang X, Raffler NA, Ley K. Transcriptional regulation of mouse l-selectin. Biochim Biophys Acta
2008;1789:146–152. [PubMed: 19041738]
130. Carlson CM, Endrizzi BT, Wu J, et al. Kruppel-like factor 2 regulates thymocyte and T-cell
migration. Nature 2006;442:299–302. [PubMed: 16855590]
131. Sinclair LV, et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control
T lymphocyte trafficking. Nat Immunol 2008;9:513–521. [PubMed: 18391955]
132. Cornish GH, Sinclair LV, Cantrell DA. Differential regulation of T-cell growth by IL-2 and IL-15.
Blood 2006;108:600–608. [PubMed: 16569767]
133. Manjunath N, et al. Effector differentiation is not prerequisite for generation of memory cytotoxic
T lymphocytes. J Clin Invest 2001;108:871–878. [PubMed: 11560956]
134. Klebanoff CA, et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor
immunity compared with effector memory T cells. Proc Natl Acad Sci USA 2005;102:9571–9576.
[PubMed: 15980149]
135. Kerdiles YM, et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7
and interleukin 7 receptor. Nat Immunol 2009;10:176–184. [PubMed: 19136962]
136. Ouyang W, Beckett O, Flavell RA, Li MO. An essential role of the Forkhead-box transcription factor
Foxo1 in control of T cell homeostasis and tolerance. Immunity 2009;30:358–371. [PubMed:
19285438]
137. Schober SL, et al. Expression of the transcription factor Lung Kruppel-Like Factor is regulated by
cytokines and correlates with survival of memory T cells in vitro and in vivo. J Immunol
1999;163:3662–3667. [PubMed: 10490960]
138. Grayson JM, Murali-Krishna K, Altman JD, Ahmed R. Gene expression in antigen-specific CD8+
T cells during viral infection. J Immunol 2001;166:795–799. [PubMed: 11145652]
139. Endrizzi BT, Jameson SC. Differential role for IL-7 in inducing lung Kruppel-like factor (Kruppel-
like factor 2) expression by naive versus activated T cells. Int Immunol 2003;15:1341–1348.
[PubMed: 14565932]
140. Lanzavecchia A, Sallusto F. Progressive differentiation and selection of the fittest in the immune
response. Nat Rev Immunol 2002;2:982–987. [PubMed: 12461571]
141. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function,
generation, and maintenance. Annu Rev Immunol 2004;22:745–763. [PubMed: 15032595]
Obar and Lefrançois Page 15
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
142. Iezzi G, Scheidegger D, Lanzavecchia A. Migration and function of antigen-primed nonpolarized
T lymphocytes in vivo. J Exp Med 2001;193:987–993. [PubMed: 11304560]
143. Weninger W, Crowley MA, Manjunath N, Von Andrian UH. Migratory properties of naive, effector,
and memory CD8(+) t cells. J Exp Med 2001;194:953–966. [PubMed: 11581317]
144. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. T cell fitness determined by signal strength. Nat
Immunol 2003;4:355–360. [PubMed: 12640450]
145. Wirth TC, Pham NL, Harty JT, Badovinac VP. High initial frequency of TCR-transgenic CD8 T
cells alters inflammation and pathogen clearance without affecting memory T cell function. Mol
Immunol 2009;47:71–78. [PubMed: 19195704]
146. Porgador A, et al. Localization, quantitation, and in situ detection of specific peptide-MHC class I
complexes using a monoclonal antibody. Immunity 1997;6:715–726. [PubMed: 9208844]
147. Janssen EM, et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T
lymphocytes. Nature 2003;421:852–856. [PubMed: 12594515]
148. Shedlock DJ, et al. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria
monocytogenes infection. J Immunol 2003;170:2053–2063. [PubMed: 12574376]
149. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell
help. Science 2003;300:339–342. [PubMed: 12690202]
150. Wang JC, Livingstone AM. Cutting edge: CD4+ T cell help can be essential for primary CD8+ T
cell responses in vivo. J Immunol 2003;171:6339–6343. [PubMed: 14662830]
151. Sun JC, Williams MA, Bevan MJ. CD4+ T cells are required for the maintenance, not programming,
of memory CD8+ T cells after acute infection. Nat Immunol 2004;5:927–933. [PubMed: 15300249]
152. Marzo AL, et al. Fully functional memory CD8 T cells in the absence of CD4 T cells. J Immunol
2004;173:969–975. [PubMed: 15240684]
153. Wilson EB, Livingstone AM. Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent
primary CD8+ T cell responses. J Immunol 2008;181:7445–7448. [PubMed: 19017930]
154. Fuse S, et al. Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation
of PD-1. J Immunol 2009;182:4244–4254. [PubMed: 19299723]
155. Bevan MJ. Helping the CD8(+) T-cell response. Nat Rev Immunol 2004;4:595–602. [PubMed:
15286726]
156. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol
2007;25:171–192. [PubMed: 17129182]
157. Castellino F, et al. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4
+ T cell-dendritic cell interaction. Nature 2006;440:890–895. [PubMed: 16612374]
158. Castellino F, Germain RN. Chemokine-guided CD4+ T cell help enhances generation of IL-6R
{alpha}highIL-7R{alpha}high prememory CD8+ T cells. J Immunol 2007;178:778–787. [PubMed:
17202339]
159. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory.
Science 2003;300:337–339. [PubMed: 12690201]
160. Parameswaran N, et al. Lack of ICAM-1 on APCs during T cell priming leads to poor generation
of central memory cells. J Immunol 2005;175:2201–2211. [PubMed: 16081787]
161. Williams MA, Tyznik AJ, Bevan MJ. Interleukin-2 signals during priming are required for secondary
expansion of CD8+ memory T cells. Nature 2006;441:890–893. [PubMed: 16778891]
162. Bachmann MF, et al. Differential role of IL-2R signaling for CD8(+) T cell responses in acute and
chronic viral infections. Eur J Immunol 2007;37:1502–1512. [PubMed: 17492805]
163. Casey KA, Mescher MF. IL-21 promotes differentiation of naive CD8 T cells to a unique effector
phenotype. J Immunol 2007;178:7640–7648. [PubMed: 17548600]
164. Malherbe L, et al. Vaccine adjuvants alter TCR-based selection thresholds. Immunity 2008;28:698–
709. [PubMed: 18450485]
165. Klonowski KD, et al. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity
2004;20:551–562. [PubMed: 15142524]
166. Stanley M, Gissmann L, Nardelli-Haefliger D. Immunobiology of human papillomavirus infection
and vaccination – implications for second generation vaccines. Vaccine 2008;26(Suppl 10):K62–
K67. [PubMed: 18847558]
Obar and Lefrançois Page 16
Ann N Y Acad Sci. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Early cell fate determination model of effector and memory CD8+ T-cell differentiation. In
this model naive CD8+ T cells become activated and form an early effector CD8+ T-cell
population, which is CD127low KLRG1low. Next, three populations of effector cells can be
identified by the peak of the CD8+ T-cell response: short-lived effector cells (SLEC) that are
CD127low KLRG1high CD62Llow, effector memory cells (TEM) memory precursor effector
cells (MPEC) that are CD127high KLRG1low CD62Llow, and central memory cells (TCM)
MPEC that are CD127high KLRG1low CD62Lhigh. Over time the SLEC population is lost
through apoptosis, while the MPEC population remains long term in the host forming the
memory CD8+ T-cell population. Additionally, with time the memory population transitions
from being predominately TEM in phenotype to TCM in nature, and this is the result of the
increased homeostatic proliferation rate of the TCM population. KLRG1, killer cell lectin-like
receptor G1; Ag, antigen; CpG, unmethylated CpG containing oligonucleotide.
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Figure 2.
Model of CD62L regulation by T-cell receptor (TCR) stimulation and γc-cytokines. Antigen-
specific CD8+ T cells are activated following engagement of the TCR with cognate peptide
antigen presented in the context of major histocompatibility complex (MHC)-I. This leads to
the activation of numerous signaling molecules, including the p110δ subunit of
phosphatidylinositol-3-kinase (PI[3]K). This leads to activation of Erk1/2, which will then
phosphorylate the TACE/Adam17 protease. Following phosphorylation the TACE/Adam17
protease will translocate to the cell membrane where it can cleave CD62L from the cell surface.
This results in the transient early downregulation of CD62L. More sustained modulation of
CD62L expression occurs at the genetic level and appears to be regulated, at least in part, by
the γc-cytokines IL-2 and IL-15. IL-2 strongly activates the p110δ subunit of PI(3)K that will
subsequently activate the mammalian target of rapamycin (mTOR) complex, while IL-15 only
weakly activates this pathway. mTOR then regulates Klf2 activity, which is known to enhance
the expression of CD62L, CCR7, and S1P1.
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